Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

Zeiss to Acquire Xradia to Expand its Microscopy Market

By BiotechDaily International staff writers
Posted on 24 Jun 2013
Print article
Zeiss (Oberkochen, Germany), an international leader of optics and optoelectronics systems recently reported on the acquisition of Xradia, Inc. (Pleasanton, CA, USA), which is expected to expand the company from light and electron microscopy into X-ray microscopy technology.

Xradia is a medium-size company that developed innovative three-dimensional (3D) X-ray microscopes for academic and industrial research purposes.

Xradia, Inc., after closing the deal, will operate under the new name Carl Zeiss X-ray Microscopy, Inc.

Related Links:
Zeiss
Xradia


Print article

Channels

Genomics/Proteomics

view channel
Image: Nanorobotic agents composed of more than 100 million flagellated bacteria - and therefore self-propelled - and loaded with drugs that moved by taking the most direct path between the drug\'s injection point and the area of the body to cure (Photo courtesy of the Montréal Nanorobotics Laboratory, Polytechnique Montréal).

Magnetically Guided Bacteria Transport Drug-Loaded Liposomes to Hypoxic Tumors

A novel transport system for toxic chemotherapeutic drugs is based on a species of bacteria that can be magnetically guided to a tumor where it releases drug-loaded liposomes into the tumor's hypoxic center.... Read more

Biochemistry

view channel
Image: A space-filling model of the anticonvulsant drug carbamazepine (Photo courtesy of Wikimedia Commons).

Wastewater May Contaminate Crops with Potentially Dangerous Pharmaceuticals

Reclaimed wastewater used to irrigate crops is contaminated with pharmaceutical residues that can be detected in the urine of those who consumed such produce. Investigators at the Hebrew University... Read more
Copyright © 2000-2016 Globetech Media. All rights reserved.